0 Évaluations

ID

16283

Description

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00093002

Lien

https://clinicaltrials.gov/show/NCT00093002

Mots-clés

  1. 09/07/2016 09/07/2016 -
Téléchargé le

9 juillet 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Breast Cancer NCT00093002

    Eligibility Breast Cancer NCT00093002

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    postmenopausal women defined as women who have stopped having menstrual periods
    Description

    postmenopausal women

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0232970
    written informed consent to participate in the trial
    Description

    written informed consent

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    biopsy confirmation of invasive breast cancer
    Description

    Biopsy result

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0405352
    UMLS CUI [1,2]
    C0853879
    evidence of hormone sensitivity
    Description

    Hormone status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0920555
    willingness to undergo biopsies
    Description

    willingness to undergo biopsies

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0021430
    UMLS CUI [1,2]
    C0405352
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    any previous treatment for breast cancer
    Description

    previous treatment

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1511300
    unwillingness to stop taking any drug known to affect sex hormonal status or a patient in which it would be inappropriate to stop.
    Description

    ID.7

    Type de données

    boolean

    any severe concurrent condition that would preclude surgery or that would jeopardize compliance with the study, e.g., uncontrolled cardiac disease or uncontrolled diabetes mellitus
    Description

    Comorbidities

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0009488
    the presence of more than one primary tumor
    Description

    Number of primary tumors

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0449788
    UMLS CUI [1,2]
    C0677930
    history of hypersensitivity to castor oil
    Description

    hypersensitivity to castor oil

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C0007343
    history of known bleeding disorders
    Description

    bleeding disorders

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0005779

    Similar models

    Eligibility Breast Cancer NCT00093002

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    postmenopausal women
    Item
    postmenopausal women defined as women who have stopped having menstrual periods
    boolean
    C0232970 (UMLS CUI [1])
    written informed consent
    Item
    written informed consent to participate in the trial
    boolean
    C0021430 (UMLS CUI [1])
    Biopsy result
    Item
    biopsy confirmation of invasive breast cancer
    boolean
    C0405352 (UMLS CUI [1,1])
    C0853879 (UMLS CUI [1,2])
    Hormone status
    Item
    evidence of hormone sensitivity
    boolean
    C0920555 (UMLS CUI [1])
    willingness to undergo biopsies
    Item
    willingness to undergo biopsies
    boolean
    C0021430 (UMLS CUI [1,1])
    C0405352 (UMLS CUI [1,2])
    Item Group
    C0680251 (UMLS CUI)
    previous treatment
    Item
    any previous treatment for breast cancer
    boolean
    C1511300 (UMLS CUI [1])
    ID.7
    Item
    unwillingness to stop taking any drug known to affect sex hormonal status or a patient in which it would be inappropriate to stop.
    boolean
    Comorbidities
    Item
    any severe concurrent condition that would preclude surgery or that would jeopardize compliance with the study, e.g., uncontrolled cardiac disease or uncontrolled diabetes mellitus
    boolean
    C0009488 (UMLS CUI [1])
    Number of primary tumors
    Item
    the presence of more than one primary tumor
    boolean
    C0449788 (UMLS CUI [1,1])
    C0677930 (UMLS CUI [1,2])
    hypersensitivity to castor oil
    Item
    history of hypersensitivity to castor oil
    boolean
    C0020517 (UMLS CUI [1,1])
    C0007343 (UMLS CUI [1,2])
    bleeding disorders
    Item
    history of known bleeding disorders
    boolean
    C0005779 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial